ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Ovid Therapeutics (OVID) Technical (Analysis) Reports Ovid Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Ovid Therapeutics (OVID)

Technical Analysis Report for NASDAQ stock OVID Ovid Therapeutics. Dated: 25 Sep 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock OVID Ovid Therapeutics then click here. or read Experts views on Ovid Therapeutics or Forecast & share price targets of Ovid Therapeutics

Ovid Therapeutics Opened at 2.49 and Closed at: 2.40, which is -3.75% of previous session's close. It moved within a range of 2.40 and 2.51
The session was a Bearish session with an average volume of 1364800, which is -11.99% of previous session's volumes.

  • The stock has fallen, and its short term trend is also negative and in a downtrend.

Support for tomorrow is 2.35 and resistance for tomorrow is 2.46
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 2.36, 2.33 resistance for tomorrow's hourly charts is 2.47, 2.55

10 Day SMA for Ovid Therapeutics (OVID) is 2.65 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Ovid Therapeutics (OVID) is 2.69 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Ovid Therapeutics (OVID) is 2.63 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 2.58 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Ovid Therapeutics is 2.28 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Ovid Therapeutics is at 2.69 and 200 DMA is at 2.28, while 50 DMA and 100 DMA are at 2.63 and 2.58 respectively

Ovid Therapeutics (OVID) moving average of 20 SMA is at 2.69 and 20 EMA is at 2.66

Ovid Therapeutics (OVID) moving average of 50 SMA is at 2.63 and 50 EMA is at 2.64

Ovid Therapeutics (OVID) moving average of 100 SMA is at 2.58 and 100 EMA is at 2.52

Ovid Therapeutics (OVID) moving average of 200 SMA is at 2.28 and 200 EMA is at 2.26

Vanda Pharmaceuticals has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Vanda Pharmaceuticals, about 9.75% more returns!

Viking Therapeutics has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Viking Therapeutics, about 24.8% more returns!

Sintx Technologies has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Sintx Technologies, about 39.62% more returns!

Repligen Corporation has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Repligen Corporation, about 21.9% more returns!

Radnet Inc has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Radnet Inc, about 9.17% more returns!

National Research has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in National Research, about 3.86% more returns!

Endra Life has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Endra Life, about 34.85% more returns!

Ac Immune has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Ac Immune, about 9.38% more returns!

Ani Pharmaceuticals has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Ani Pharmaceuticals, about 15.9% more returns!

Chemocentryx Inc has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Chemocentryx Inc, about 3.19% more returns!

Ensign Group has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Ensign Group, about 15.56% more returns!

Genprex Inc has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Genprex Inc, about 3.94% more returns!

Harrow Health has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Harrow Health, about 3.02% more returns!

Atyr Pharma has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Atyr Pharma, about 3.06% more returns!

Lantheus Holdings has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Lantheus Holdings, about 13.27% more returns!

Liquidia Technologies has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Liquidia Technologies, about 15.38% more returns!

Ovid Therapeutics Technical analysis of indicators

Price action analysis of Ovid Therapeutics (OVID) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Ovid Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Ovid Therapeutics in short term and the sell signal is strong.

Ovid Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down

CCI has generated a SELL signal for Ovid Therapeutics in short term and SELL signal is strong!

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Ovid Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2.66 and Ovid Therapeutics OVID stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Ovid Therapeutics OVID stock. Volume based technical analysis of Ovid Therapeutics OVID stock is negative.

Ovid Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock OVID Ovid Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And OVID Experts View which covers a lot of information including buying and selling signals

OVID future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Ovid Therapeutics or View Candle Stick Charts here

Chart Ovid Therapeutics (OVID)  Technical (Analysis) Reports Ovid Therapeutics [

Videos related to: Ovid Therapeutics (OVID) Technical (Analysis) Reports Ovid Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Ovid Therapeutics (OVID)  Technical (Analysis) Reports Ovid Therapeutics [

 

Back to top